Advertisement
Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal
Open Access

The GPR40 Full Agonist SCO-267 Improves Liver Parameters in a Mouse Model of Nonalcoholic Fatty Liver Disease without Affecting Glucose or Body Weight

Mitsugi Ookawara, Keisuke Matsuda, Masanori Watanabe and Yusuke Moritoh
Journal of Pharmacology and Experimental Therapeutics October 2020, 375 (1) 21-27; DOI: https://doi.org/10.1124/jpet.120.000046

Article Information

vol. 375 no. 1 21-27
DOI 
https://doi.org/10.1124/jpet.120.000046
PubMed 
32719069
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received April 11, 2020
  • Accepted July 21, 2020
  • Published online September 12, 2020.

Article Versions

Copyright & Usage 
Copyright © 2020 The Author(s) This is an open access article distributed under the CC BY Attribution 4.0 International license.

Author Information

  1. Mitsugi Ookawara,
  2. Keisuke Matsuda,
  3. Masanori Watanabe, and
  4. Yusuke Moritoh
  1. SCOHIA PHARMA, Inc., Kanagawa, Japan
  1. Address correspondence to:
    Yusuke Moritoh, Research and Development Division, SCOHIA PHARMA, Inc., 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan. E-mail: yusuke.moritoh{at}scohia.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: July 2020 to October 2020

AbstractFullPdf
Jul 20201820164
Aug 20202260118
Sep 202028410385
Oct 20201315150

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal

GPR40 Full Agonist for Nonalcoholic Fatty Liver Disease

Mitsugi Ookawara, Keisuke Matsuda, Masanori Watanabe and Yusuke Moritoh
Journal of Pharmacology and Experimental Therapeutics October 1, 2020, 375 (1) 21-27; DOI: https://doi.org/10.1124/jpet.120.000046
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section